Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Frontiers Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers – current evidence and future directions

Personalised circulating tumour DNA assay with large-scale

Dissected subgroups predict the risk of recurrence of stage II

PDF] Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA

Previous Trials of ctDNA Analysis in Patients With CRC

Development and validation of postoperative circulating tumor DNA

Peripheral surrogates of tumor burden to guide chemotherapeutic

PUBLICATIONS – Cristian Tomasetti

Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020

Adjuvant chemotherapy decision-making in stage II colon